[
  {
    "id": "scc-general_46444_1750166914.txt-1",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#definitiongeneral476983",
    "clean_content": "Definition / general\n\n* Squamous cell carcinoma (SCC) is a malignant neoplasm that arises from the mucosal epithelium of the oral cavity and shows variable squamous differentiation"
  },
  {
    "id": "scc-general_46444_1750166914.txt-2",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#essentialfeatures476984",
    "clean_content": "Essential features\n\n* Most common cancer of the oral cavity, with a variable clinical appearance and a predilection for the ventrolateral tongue* Associated with tobacco, alcohol and betel quid* Malignancy of squamous cells with varying degrees of keratinization"
  },
  {
    "id": "scc-general_46444_1750166914.txt-3",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#icdcoding476986",
    "clean_content": "ICD coding\n\n* ICD-10: [C00 - C14](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C00-C14) - malignant neoplasms of lip, oral cavity and pharynx"
  },
  {
    "id": "scc-general_46444_1750166914.txt-4",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#epidemiology476987",
    "clean_content": "Epidemiology\n\n* > 90% of cancers in the oral cavity are SCC* Globally, the highest rates are seen in Melanesia and South Central Asia; it is the leading cause of cancer related death for men in India ([CA Cancer J Clin 2021;71:209](33538338))* For the United States, the American Cancer Society estimates ~58,000 new cases of oral and oropharyngeal cancers in 2024 with 12,230 deaths ([American Cancer Society: Key Statistics for Oral Cavity and Oropharyngeal Cancers [Accessed 2 February 2024]](https://www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/about/key-statistics.html))* M > F* Average age is 63* Can occur in younger patients, especially in the setting of dyskeratosis congenita or Fanconi anemia ([J Pediatr Hematol Oncol 2019;41:501](30951027), [Head Neck Pathol 2021;15:1099](33797696))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-5",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#sites476988",
    "clean_content": "Sites\n\n* Can occur at any oral mucosal site (mucosal lip, buccal mucosa, alveolar ridge, floor of the mouth, hard palate, mobile tongue)* Classic high risk locations are ventrolateral tongue and floor of mouth* Patients can develop second primaries, synchronous or metachronous, with field cancerization as a probable hypothesis ([Head Neck 2020;42:1848](32057158), [Oral Oncol 2015;51:643](25920765))* Proliferative (verrucous) leukoplakia lesions have a high risk of malignant transformation, especially in locations such as the gingiva ([Head Neck Pathol 2021;15:572](33415517))* Spread typically occurs via the lymphatic system to cervical lymph nodes"
  },
  {
    "id": "scc-general_46444_1750166914.txt-6",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#pathophysiology476989",
    "clean_content": "Pathophysiology\n\n* Multifactorial with accumulation of genetic alterations\n  + Loss of function of *TP53* mutations and *CDKN2A* inactivation are frequently seen ([Nature 2015;517:576](25631445))* Oral potentially malignant disorders, many of which harbor some degree of epithelial dysplasia, are associated with a risk of malignant progression ([Head Neck Pathol 2019;13:423](30887394))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-7",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#etiology476990",
    "clean_content": "Etiology\n\n* Tobacco ([Int J Cancer 2008;122:155](17893872))* Alcohol ([Lancet Oncol 2021;22:1071](34270924))* Significantly higher risk with synergistic consumption of alcohol and tobacco ([Clin Oral Investig 2019;23:2849](31111280))* Betel quid, gutka, pan masala ([Curr Oncol Rep 2019;21:53](31028548))* Smokeless tobacco products ([Nicotine Tob Res 2019;21:1162](29790998))* Ultraviolet (UV) radiation for lip squamous cell carcinoma ([Laryngoscope 2018;128:84](28573764))* High risk human papillomavirus (HPV) is strongly associated with oropharyngeal squamous cell carcinoma; in contrast, 4.4% of oral squamous cell carcinoma cases are associated with high risk HPV ([Braz J Otorhinolaryngol 2021;87:346](33339760))* Controversy regarding oral lichen planus and malignant transformation is unresolved ([Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122:332](27401683))* Due to confounding variables, chronic mechanical irritation has not been established as an independent risk factor ([Bosn J Basic Med Sci 2021;21:647](33823123))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-8",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#clinicalfeatures476992",
    "clean_content": "Clinical features\n\n* Varied clinical presentation, including exophytic, endophytic, white (leukoplakia), red (erythroplakia), nonhealing ulceration* May be preceded by or associated with an oral, potentially malignant disorder* Clinical factors associated with malignancy include nonhomogenous leukoplakia, erythroplakia, induration, deep ulceration, exophytic component and pain ([Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130:264](32561250))* Patient factors associated with malignant transformation include heavy tobacco smoking (> 20 pack years), heavy alcohol consumption (> 14 drinks/week for women and 21 drinks/week in men), immunosuppression ([Head Neck 2021;43:3552](34472151))* Firm, fixed, nontender cervical lymph nodes may indicate regional spread"
  },
  {
    "id": "scc-general_46444_1750166914.txt-9",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#diagnosis476993",
    "clean_content": "Diagnosis\n\n* U.S. Preventive Services Task Force concludes that for primary care providers, current evidence is insufficient to assess balance of benefits and harms of oral cancer screening in asymptomatic adults ([Ann Intern Med 2014;160:55](24276469))* Visual and tactile exams of the oral cavity are often performed by oral health care providers and otolaryngologists* Immediate tissue biopsy with histopathologic examination for definitive diagnosis ([J Am Dent Assoc 2017;148:712](28958308))* 48.4% of cases are regional at diagnosis ([NIH: Oral Cavity and Pharynx Stage Distribution of SEER Incidence Cases, 2011-2020 [Accessed 2 February 2024]](https://seer.cancer.gov/statistics-network/explorer/application.html?site=3&data_type=1&graph_type=4&compareBy=sex&chk_sex_1=1∽̱=1&age_range=1&advopt_precision=1&hdn_view=0))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-10",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#radiologydescription476995",
    "clean_content": "Radiology description\n\n* Invasive, advanced tumors may be detected on dental radiographs as destruction of underlying bone producing an ill defined radiolucency* Positron emission tomography (PET), computed tomography (CT) and magnetic resonance imaging (MRI) can be used to determine the presence and extent of disease* Carcinomas arising in the jaw bones without a mucosal origin are primary intraosseous squamous cell carcinoma and are not discussed here ([Head Neck Pathol 2021;15:608](33044723))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-11",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#radiologyimages476996",
    "clean_content": "Radiology images\n\nContributed by Sarah Glass, D.D.S.  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass04.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass04.jpg)\n\nMandible invasion"
  },
  {
    "id": "scc-general_46444_1750166914.txt-12",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#prognosticfactors476997",
    "clean_content": "Prognostic factors\n\n* 5 year survival rate of 68.5% ([NIH: Cancer Stat Facts - Oral Cavity and Pharynx Cancer [Accessed 2 February 2024]](https://seer.cancer.gov/statfacts/html/oralcav.html))* Depth of invasion (DOI) and extranodal extension (ENE) were added to the AJCC staging 8th edition and are associated with upstaging ([Oral Oncol 2018;85:82](30220324))* Bone invasion is correlated with a worse prognosis (and invasion through cortical bone into medullary bone provides the tumor with AJCC stage T4a) ([Arch Pathol Lab Med 2019;143:439](30500296))* Noncohesive pattern of invasion is an adverse prognostic factor ([Arch Pathol Lab Med 2019;143:439](30500296))* Perineural invasion is associated with poor disease specific survival ([J Oral Pathol Med 2020;49:994](32533593))* Lymphovascular invasion may serve as a prognostic predictor of metastasis ([Oral Surg Oral Med Oral Pathol Oral Radiol 2021;131:319](33309267))* Margin of < 1 mm is associated with increased risk of local recurrence ([JAMA Otolaryngol Head Neck Surg 2017;143:1166](28445581))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-13",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#casereports476998",
    "clean_content": "Case reports\n\n* 28 year old woman with asymptomatic tumor of the left mandibular gingiva and Fanconi anemia ([Case Rep Dent 2021;2021:5571649](34258076))* 63 year old man with pain and swelling on the right lower jaw ([Head Neck Pathol 2021;15:1313](33398682))* 66 year old woman with fungating ulcerative mass on the left lateral tongue ([Head Neck Pathol 2017;11:552](28342060))* 70 year old woman with ulcerated mass on the lateral border of the tongue ([Head Neck Pathol 2018;12:580](29427031))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-14",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#treatment476999",
    "clean_content": "Treatment\n\n* Early staged lesions are often treated with surgery* Patients with early stage cancer may benefit from elective neck dissection ([N Engl J Med 2015;373:521](26027881))* Moderate staged lesions are often treated with surgery, radiation therapy or chemotherapy* Patients with recurrent or metastatic head and neck cancer may benefit from immunotherapeutic agents ([J Immunother Cancer 2019;7:184](31307547))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-15",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Clinical images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#clinicalimages477000",
    "clean_content": "Clinical images\n\nContributed by Sarah Glass, D.D.S.  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass01.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass01.jpeg)\n\nExophytic mass lateral tongue\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass02.jpeg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass02.jpeg)\n\nUlceration ventrolateral tongue\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass03.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass03.jpg)\n\nRed-white maxillary gingiva"
  },
  {
    "id": "scc-general_46444_1750166914.txt-16",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#grossdescription477001",
    "clean_content": "Gross description\n\n* Site of involvement, tumor laterality and operative procedure should be communicated from the surgeon ([Arch Pathol Lab Med 2019;143:439](30500296))* Gross examination of a specimen may not entirely reflect microscopic tumor extent, as dysplasia, ulceration or inflammation may appear as tumor on macroscopic examination ([Arch Pathol Lab Med 2019;143:439](30500296))* White infiltrating tumor on cross section"
  },
  {
    "id": "scc-general_46444_1750166914.txt-17",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#grossimages477002",
    "clean_content": "Gross images\n\nContributed by Kathleen Higgins, D.D.S., M.S., Stephen Roth, D.D.S. and Kathleen Schultz, D.M.D.  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins01a.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins01a.jpg)\n\nGlossectomy specimen\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins01b.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins01b.jpg)\n\nGlossectomy specimen cross section\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz02a.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz02a.jpg)\n\nResection  \n lateral view\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz02b.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz02b.jpg)\n\nResection superior view\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz02c.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz02c.jpg)\n\nResection anterior view\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz03.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccRothSchultz03.jpg)\n\nGlossectomy specimen"
  },
  {
    "id": "scc-general_46444_1750166914.txt-18",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Frozen section description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#frozensectiondescription477003",
    "clean_content": "Frozen section description\n\n* Frozen section analysis can be used to evaluate tumor diagnosis and margin status\n  + Results are highly specific but only moderately sensitive when compared with final margins ([Laryngoscope 2000;110:1773](11037842))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-19",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Frozen section images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#frozensectionimages477004",
    "clean_content": "Frozen section images\n\nContributed by Kathleen Higgins, D.D.S., M.S. and Kathleen Schultz, D.M.D.  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins02.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins02.jpg)\n\nTumor with margins\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccSchultz01a.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccSchultz01a.jpg)\n \n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccSchultz01b.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccSchultz01b.jpg)\n\nInvasive carcinoma"
  },
  {
    "id": "scc-general_46444_1750166914.txt-20",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#microscopichistologicdescription477005",
    "clean_content": "Microscopic (histologic) description\n\n* Dysplastic stratified squamous epithelium that extends through the basement membrane and into the underlying fibrous connective tissue without attachment to the surface* Malignant epithelial cells show eosinophilic cytoplasm, hyperchromatic nuclei, pleomorphism, mitotic activity, individual cell keratinization and intercellular bridging* Superficial or microinvasion can be used to describe the earliest moment of invasion* Malignant epithelium can invade fibrous connective tissue in islands, cords or individual cells* Keratin pearls of round, eosinophilic, concentric layers of keratin can be seen and are associated with well differentiated tumors* 3 histologic grades for conventional squamous cell carcinoma include well, moderately and poorly differentiated based on amount of keratinization, mitotic activity, cellular and nuclear pleomorphism, pattern of invasion and host response ([Arch Pathol Lab Med 2019;143:439](30500296))* Histologic variants are listed below ([Arch Pathol Lab Med 2019;143:439](30500296))\n              + [Verrucous squamous cell carcinoma](https://www.pathologyoutlines.com/topic/oralcavityverrucous.html)+ Papillary squamous cell carcinoma\n                  - Exophytic growth demonstrating multiple, thin keratinized papillary projections with fibrovascular cores or rounded, bulbous projections with nonkeratinized epithelium- Malignant epithelial cells show an increased N:C ratio, prominent nucleoli and mitotic figures- Obvious invasive components uncommon ([Ann Diagn Pathol 2013;17:18](22672806))+ Spindle cell squamous cell carcinoma\n                    - Also called sarcomatoid- Monoclonal, evolving from conventional squamous carcinoma with dedifferentiation ([Head Neck Pathol 2010;4:265](20730609))- Often polypoid configuration on biopsy; tumor may be ulcerated- Overlying epithelium may show carcinoma in situ or dysplasia with elongation and spindling of the basal epithelial cells- Nest of moderately or poorly differentiated conventional squamous cell carcinoma may be intricately mixed sarcomatoid component- High mitotic count with bizarre, atypical mitotic figures- Dense and eosinophilic cytoplasm- Cells can be arranged in various patterns with variable amount of intervening matrix, which can mimic mesenchymal malignancies- Metaplastic mesenchymal elements such as bone or cartilage not identified+ Carcinoma cuniculatum\n                      - Well differentiated squamous epithelium with minimal to no cytologic atypia- Unique deeply infiltrative, large sized, branching, keratin filled cavities, resembling rabbit burrows ([Head Neck Pathol 2022;16:213](34076846))- Lymphocytic infiltrate surrounding epithelial tunnels and intraepithelial neutrophilic microabscesses+ Basaloid squamous cell carcinoma\n                        - Lobules, nests or cribriform patterns of small basaloid cells with peripheral palisading and a thick basement membrane- Cells have minimal cytoplasm, are moderately pleomorphic with hyperchromatic nuclei and often abruptly transition to squamous epithelium- Single cell necrosis and comedonecrosis are common; often contiguous with carcinoma in situ in surface epithelium- Frequent mitotic activity, stroma is often hyalinized or myxoid; variable pseudoglandular spaces resembling adenoid cystic carcinoma- Rarely has a spindle cell component ([Arch Pathol Lab Med 1995;119:181](7848067))+ Acantholytic squamous cell carcinoma\n                          - Pseudoglandular structures, dyskeratotic cells and prominent acantholysis within tumor islands ([Head Neck Pathol 2022;16:388](34378166))+ Adenosquamous cell carcinoma\n                            - Distinct squamous and glandular differentiation in close proximity with blending and intermixing- Typically presents as a superficial squamous cell carcinoma transitioning to a deeper adenocarcinoma ([Head Neck Pathol 2018;12:576](29243024))+ Lymphoepithelial carcinoma\n                              - Undifferentiated squamous cell carcinoma associated with a prominent, nonneoplastic lymphoplasmacytic cell infiltrate ([Head Neck Pathol 2020;14:1001](32462279))- Definitive squamous differentiation may be present but is usually limited, while a basaloid morphology can be identified ([Head Neck Pathol 2012;6:445](22926973))- Epstein-Barr virus (EBV) associated- Morphologically indistinguishable from undifferentiated nasopharyngeal carcinoma ([Head Neck Pathol 2020;14:1001](32462279))* Although more often seen in salivary gland neoplasms and odontogenic tumors, oral squamous cell carcinoma may rarely show clear cell change ([Cureus 2022;14:e25057](35719807))* American Joint Committee on Cancer (AJCC) 8th edition is currently used for staging (see [Staging - oral cavity](https://www.pathologyoutlines.com/topic/oralcavitytnm.html))* College of American Pathologists (CAP) protocol including TNM ([CAP: Protocol for the Examination of Specimens from Patients with Cancers of the Lip and Oral Cavity [Accessed 2 February 2024]](https://cap.objects.frb.io/protocols/cp-headandneck-lip-oralcavity-17protocol-4001.pdf))* Data set elements: operative procedure, specimens submitted, tumor dimensions, histologic tumor type, histologic tumor grade, pattern of invasive front, bone invasion, perineural invasion, lymphovascular invasion, margin status, pathologic staging ([Arch Pathol Lab Med 2019;143:439](30500296))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-21",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#microscopichistologicimages477006",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Kathleen Higgins, D.D.S., M.S., Duane Schafer, D.D.S., M.S. and Sarah Glass, D.D.S.  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins03.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins03.jpg)\n\nTumor with margins\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccSchafer01.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccSchafer01.jpg)\n\nBasement membrane breach\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass05.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass05.jpg)\n\nKeratin pearl\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass06.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass06.jpg)\n\nMuscle invasion\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass07.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass07.jpg)\n\nIndividual cell keratinization\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass08.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass08.jpg)\n\nImpressive pleomorphism\n\n  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins04.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccHiggins04.jpg)\n\nSurrounding nerve\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass09a.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass09a.jpg)\n\nScattered malignant cells\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass10.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass10.jpg)\n\nBasaloid variant\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass11.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass11.jpg)\n\nAdenosquamous variant\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass12.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass12.jpg)\n\nVerrucous carcinoma\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass13.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass13.jpg)\n\nPapillary variant\n\n  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass14.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass14.jpg)\n\nAcantholytic variant\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass15.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass15.jpg)\n\nSpindle variant\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass16.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass16.jpg)\n\nCuniculatum variant\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass09b.jpg)](https://www.pathologyoutlines.com/imgau/oralcavitysccGlass09b.jpg)\n\nCytokeratin positive"
  },
  {
    "id": "scc-general_46444_1750166914.txt-22",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#cytologydescription477008",
    "clean_content": "Cytology description\n\n* Cytology is not routinely recommended for evaluation of intraoral lesions suspicious for malignancy ([J Am Dent Assoc 2017;148:712](28958308))* Fine needle aspiration can identify regional spread to cervical lymph nodes"
  },
  {
    "id": "scc-general_46444_1750166914.txt-23",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#positivestains477012",
    "clean_content": "Positive stains\n\n* [Cytokeratin](https://www.pathologyoutlines.com/topic/stainsckgeneral.html) stains are positive: [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [CK5/6](https://www.pathologyoutlines.com/topic/stainsck5and6.html), [p63](https://www.pathologyoutlines.com/topic/stainsp63.html), [p40](https://www.pathologyoutlines.com/topic/stainsp40.html) ([Arch Pathol Lab Med 2019;143:439](30500296))\n  + This can be helpful to support epithelial origin in poorly differentiated tumors"
  },
  {
    "id": "scc-general_46444_1750166914.txt-24",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#negativestains477013",
    "clean_content": "Negative stains\n\n* Pathologists should not routinely perform high risk [HPV](https://www.pathologyoutlines.com/topic/stainshpv.html) testing on patients with nonoropharyngeal primary head and neck tumors ([Arch Pathol Lab Med 2018;142:559](29251996))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-25",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#molecularcytogeneticsdescription477016",
    "clean_content": "Molecular / cytogenetics description\n\n* Due to advances in targeted therapy, some centers are evaluating the mutational profiles of tumors ([Nat Rev Dis Primers 2020;6:92](33243986))"
  },
  {
    "id": "scc-general_46444_1750166914.txt-26",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#samplepathologyreport477019",
    "clean_content": "Sample pathology report\n\n* Right lateral tongue, incisional biopsy:\n  + Squamous cell carcinoma, well differentiated (see comment)+ Comment: Tumor islands are present at all surgical margins. Depth of invasion is at least 3 mm. Perineural and lymphovascular invasion are identified."
  },
  {
    "id": "scc-general_46444_1750166914.txt-27",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#differentialdiagnosis477020",
    "clean_content": "Differential diagnosis\n\n* [Pseudoepitheliomatous hyperplasia](https://www.pathologyoutlines.com/topic/oralcavitypseudoephyperplasia.html) ([Arch Otolaryngol Head Neck Surg 2003;129:127](12525208)):\n  + Benign lesions in the oral cavity, such as [granular cell tumor](https://www.pathologyoutlines.com/topic/oralcavitygct.html), may show pseudoepitheliomatous hyperplasia of the overlying squamous mucosa+ Granular cell tumors are [S100](https://www.pathologyoutlines.com/topic/stainss100.html) positive and occur on the dorsal tongue, an uncommon location for oral squamous cell carcinoma* [Mucoepidermoid carcinoma](https://www.pathologyoutlines.com/topic/salivaryglandsMEC.html):\n    + May be difficult to distinguish high grade mucoepidermoid carcinoma from squamous cell carcinoma, adenosquamous variant+ High grade tumors may show predominantly squamous and intermediate cells with infrequent mucous cells* **Basaloid salivary gland tumors** ([Semin Diagn Pathol 2022;39:17](34750022)):\n      + May be difficult to distinguish basaloid salivary gland tumors from squamous cell carcinoma, basaloid variant+ Basal / myoepithelial cell population can be evaluated with [p40](https://www.pathologyoutlines.com/topic/stainsp40.html) / [p63](https://www.pathologyoutlines.com/topic/stainsp63.html)* [Oral malignant melanoma](https://www.pathologyoutlines.com/topic/oralcavitymelanoma.html):\n        + May be difficult to distinguish amelanotic melanoma from a poorly differentiated squamous cell carcinoma+ Positive melanocytic markers: [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html), [MART1](https://www.pathologyoutlines.com/topic/stainsmart1.html), [SOX10](https://www.pathologyoutlines.com/topic/stainssox10.html)* [Epithelioid sarcoma](https://www.pathologyoutlines.com/topic/softtissueepithelioidsarcoma.html) ([Ann Otol Rhinol Laryngol 2021;130:416](32814436)):\n          + Epithelioid sarcoma may express epithelial markers but most importantly does not express [INI1](https://www.pathologyoutlines.com/topic/stainsini1.html)* [Angiosarcoma](https://www.pathologyoutlines.com/topic/softtissueangiosarcoma.html) ([Head Face Med 2008;4:17](18671846)):\n            + May be difficult to distinguish angiosarcoma from squamous cell carcinoma, acantholytic variant+ Expresses endothelial cell markers such as [FLI1](https://www.pathologyoutlines.com/topic/stainsfli1.html)* **Metastatic squamous cell carcinoma to the oral cavity**:\n              + Metastases may involve the soft tissue or bone+ First manifestation of disease in 25 - 30% of patients ([Head Neck Pathol 2022;16:802](35438419))+ Histopathology is variable+ Patient history can be helpful, especially the ability to compare histopathology of known primary with current specimen+ Overlying mucosa uninvolved with lack of overt surface dysplasia* **Neuroepithelial structures**, including the [juxtaoral organ of Chievitz](https://www.pathologyoutlines.com/topic/oralcavitynormalanatomy.html):\n                + Avoid misinterpretation as carcinoma showing neural invasion ([Head Neck Pathol 2020;14:876](32016784))+ Located lingual to the mandible, buccal to the mandible and within the posterior tongue+ Smalls islands of squamoid epithelium in close association with small nerves or the taste buds+ Absence of keratinization, cytological atypia and mitotic activity"
  },
  {
    "id": "scc-general_46444_1750166914.txt-28",
    "source_document": "scc-general_46444_1750166914.txt",
    "parent": "oral-cavity-amp-oropharynx_84",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/oralcavityscc.html#additionalreferences477021",
    "clean_content": "Additional references\n\n* [WHO Classification of Tumours Editorial Board: Head and Neck Tumours, 5th Edition, 2024](https://www.amazon.com/exec/obidos/ASIN/9283245148/pathologyoutl-20)"
  }
]